Galactomyces Ferment Filtrate, Glycerin, Cetyl Ethylhexanoate, Propanediol, Dicaprylyl Carbonate, 1, 2-Hexanediol, Betaine, Cetearyl Alcohol, Polyglyceryl-10 Laurate, Methyl Trimethicone, Silica, Cetearyl Olivate, Panthenol, Phenyl Trimethicone, Potassium Cetyl Phosphate, Water, Sorbitan Olivate, Bisabolol, Ammonium Polyacryloyldimethyl Taurate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Dipropylene Glycol, Squalane, Laminaria Japonica Extract, Eclipta Prostrata Leaf Extract, 3-O-Ethyl Ascorbic Acid, Glutathione, Ethylhexylglycerin, Fragrance, Lavandula Angustifolia (Lavender) Oil, Coptis Japonica Root Extract, Xanthan Gum, Butylene Glycol, Adenosine, Fructooligosaccharides, Sorbitan Isostearate, T-Butyl Alcohol, Hydrogenated Lecithin, Beta-Glucan, Hydrolyzed Hyaluronic Acid, Ascorbic Acid, Tocopherol, Allantoin, Ceramide NP, Oryza Sativa (Rice) Bran Oil, Oryza Sativa (Rice) Bran Extract, Glyceryl Stearate, Phytosphingosine, Cholesterol, Ceramide AP, Ceramide AS, Ceramide NS, Caprylyl Glycol, Ceramide NG, Ceramide EOP, Linalool, Limonene Ingredients may change
10.22608/APO.2016126 274
I am no expert ,just looking for answers,like many of us
In proximity labeling experiments, BirA has a high local concentration because the protein of interest that it is fused to is interacting with other proteins that BirA is biotinylating
MASLD is the most common chronic liver disease and comprises histopathological disorders that range from the accumulation of triglycerides in the liver (steatosis) to non-alcoholic steatohepatitis (MASH) characterized by the presence of inflammation and fibrosis in the liver [14]
